Jenamazol

Clotrimazole, the active ingredient in Jenamazol, is a azole antifungal presented as a tablet for vaginal use. It treats vulvovaginal candidiasis and other yeast infections in women, and is formulated for local application to relieve symptoms and eradicate the fungal organism.

GNH USA supplies Jenamazol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP guidelines and provides regulatory documentation for global distribution.

Jenamazol, an azole antifungal, is used to treat fungal infections of the vaginal mucosa.

Vulvovaginal candidiasis: reduces fungal load and alleviates itching, burning and discharge. Yeast infection of the vagina: eliminates Candida species responsible for infection. Recurrent vulvovaginal candidiasis: helps prevent repeated episodes when used as directed.

Clotrimazole may cause local or systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Vaginal irritation or burning - Itching or mild rash at the application site - Increased vaginal discharge

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis, facial swelling) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Liver enzyme elevation with extensive absorption

Before using Jenamazol, consider the following safety measures.

Pregnancy: consult a healthcare professional before use. Breastfeeding: discuss safety with a physician. Allergy: avoid if hypersensitivity to clotrimazole or other azoles. Concurrent vaginal medication: do not use with other antifungal products without advice. Duration of use: limit to the recommended period to prevent resistance. Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Clotrimazole can interact with other medicines; review the following categories.

Major Interactions (Avoid): - Concurrent use of other azole antifungals in the vagina: may increase local irritation. - Systemic CYP3A4 inhibitors combined with extensive vaginal application: risk of increased systemic absorption.

Moderate Interactions (Monitor Closely): - Use with hormonal contraceptives: no known effect but monitor for irritation. - Co‑administration with spermicides or lubricants: may alter drug efficacy. - Topical steroids applied nearby: may reduce antifungal activity.